Stock listing

NASDAQ:LBPH Longboard Pharmaceuticals Inc Stock

Follow Longboard Pharmaceuticals Inc into a list and get an email when it puts out news.

Delisted NASDAQ:LBPH no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:LBPH
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Longboard Pharmaceuticals Inc on 6ix

Calls
1 call with a replay · 1 with a transcript · latest Aug 1, 2024
Decks
9 decks · latest Aug 1, 2024

Events

CallWhenStatus
Longboard Pharmaceuticals (LBPH) Q2 2024 Earnings CallThu, Aug 01, 2024 · 4:30 PM ETReplay

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (August 2024)Investor deck32 slidesAug 1, 2024
Technical Presentation (June 2024)Technical5 slidesJun 10, 2024
Investor Presentation (March 2024)Investor deck41 slidesMar 12, 2024
Technical Presentation (January 2024)Technical21 slidesJan 2, 2024
Investor Presentation (November 2023)Investor deck50 slidesNov 29, 2023
Investor Day (October 2023)Investor day49 slidesOct 11, 2023
Investor Presentation (December 2022)Investor deck24 slidesDec 5, 2022
Investor Presentation (January 2022)Investor deck33 slidesJan 10, 2022
Investor Presentation (December 2021)Investor deck35 slidesDec 1, 2021

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Paul Sekhri
Other companies: Apnimed, Inc. (Director · Since at least Jul 30, 2026); vTv Therapeutics Inc. (Chairman of the Board, President and Chief Executive Officer · Since at least Aug 1, 2022); Veeva Systems Inc. (Director · Since at least Jun 22, 2016); Axcella Health Inc (Director · May 19, 2022 – May 19, 2022 · Past); BiomX Inc. (Director · Oct 2, 2020 – Jul 28, 2021 · Past); Enumeral Biomedical Holdings Inc (Director · Dec 9, 2016 – Dec 9, 2016 · Past); Alpine Immune Sciences Inc (Director · Sep 12, 2016 – Jan 2, 2020 · Past)
Director · Mar 11, 2021 – Dec 2, 2024 · Past
Brandi Roberts
Other companies: Definium Therapeutics, Inc. (Chief Financial Officer · Since at least Jun 2, 2025); TFF Pharmaceuticals Inc (Director · Mar 25, 2022 – Jul 3, 2024 · Past); Lineage Cell Therapeutics, Inc. (CFO & SVP Finance · Jan 7, 2019 – Mar 17, 2020 · Past); Savara, Inc. (Chief Financial Officer & SVP · Jun 19, 2013 – Jan 20, 2017 · Past)
Executive VP and CFO · Mar 11, 2021 – Dec 2, 2024 · Past
Kevin Lind
Other companies: Apnimed, Inc. (Chief Executive Officer · Since at least Jul 30, 2026); Avalo Therapeutics, Inc. (Director · Since at least Sep 22, 2025); Arena Pharmaceuticals Inc (Executive VP and CFO · Jun 15, 2016 – Mar 1, 2020 · Past)
President and CEO, Director · Mar 11, 2021 – Dec 2, 2024 · Past
Vincent Aurentz
Other companies: Inhibikase Therapeutics, Inc. (Director · Since at least Feb 21, 2025); Arena Pharmaceuticals Inc (Executive VP and CBO · Aug 15, 2016 – Mar 11, 2022 · Past); EPIRUS Biopharmaceuticals Inc (Chief Business Officer · Nov 9, 2015 – May 27, 2016 · Past)
Director · Mar 11, 2021 – Dec 2, 2024 · Past
Casey Lynch
Other companies: Quince Therapeutics, Inc. (Chief Executive Officer, Director · May 8, 2019 – Jan 3, 2022 · Past)
Director · Mar 11, 2021 – Dec 2, 2024 · Past
Philip PereraCMO · Mar 11, 2021 – Feb 9, 2022 · Past

Open People

Log in to ask 6ix AI your own questions about Longboard Pharmaceuticals Inc.